Posted On: 04/27/2014 9:37:06 AM
Post# of 72750
$PFE Recent News
AstraZeneca, Smith & Nephew push FTSE to 7-week high 12:31 p.m. April 24, 2014 - Sara Sjolin
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
Glaxo, AstraZeneca lead U.K. stocks to two-week high 12:50 p.m. April 22, 2014 - Carla Mozee
Drug stocks drive European markets higher 12:22 p.m. April 22, 2014 - Carla Mozee
Pfizer Psoriasis treatment shows positive results 9:35 a.m. April 22, 2014 - MarketWatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
European stocks rise as AstraZeneca, Glaxo climb 3:40 a.m. April 22, 2014 - Carla Mozee
Investors drive up AstraZeneca despite questions over potential Pfizer deal 12:00 p.m. April 21, 2014 - blogs.marketwatch.com
Pfizer held now-discontinued talks with AstraZeneca: report 2:18 a.m. April 21, 2014 - Barbara Kollmeyer
Acura Pharmaceuticals ends Pfizer licensing pact 7:10 a.m. April 10, 2014 - MarketWatch.com
U.S. stocks fall; Nasdaq 3-day loss worst since 2011 4:48 p.m. April 7, 2014 - Victor Reklaitis
Newscast: Wall Street extends recent selloff 4:28 p.m. April 7, 2014 - MarketWatch
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
Pfizer shares drop despite positive test for breast-cancer drug 1:03 p.m. April 7, 2014 - blogs.marketwatch.com
Pfizer drops 2.5% to lead Dow decliners 9:35 a.m. April 7, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Pfizer anti-cholesterol drug meets main study goal 9:28 a.m. March 27, 2014 - MarketWatch.com
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. April 26, 2014 - 247WallSt.com
Assessing Pfizer's Future 3:43 a.m. April 26, 2014 - Barrons.com
Stocks Fall Slightly After a Jittery Friday 1:44 a.m. April 26, 2014 - Barrons.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2014 Update 1:31 p.m. April 25, 2014 - Seeking Alpha
FDA Reviewing Psychiatric Side Effects of Pfizer's Chantix 11:50 a.m. April 25, 2014 - The Wall Street Journal Interactive Edition
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 10:34 a.m. April 25, 2014 - Seeking Alpha
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. April 25, 2014 - Zacks.com
Cramer's Mad Money - Revenge Of The Nerds (4/24/14) 6:45 a.m. April 25, 2014 - Seeking Alpha
2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked 5:55 a.m. April 25, 2014 - InvestorPlace.com
Generics Dent AstraZeneca Profit 3:12 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop 12:31 p.m. April 24, 2014 - TheStreet.com
AstraZeneca Suffering from Split Personality 11:27 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Actavis Settles Celebrex Case With Pfizer 11:03 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Dow Today: Pfizer (PFE) Lower 11:00 a.m. April 24, 2014 - TheStreet.com
Trade-Ideas: Pfizer (PFE) Is Today's "Roof Leaker" Stock 10:12 a.m. April 24, 2014 - TheStreet.com
AstraZeneca could sell, spin off $15B worth of assets 7:59 a.m. April 24, 2014 - Seeking Alpha
30 And Under Portfolio: Q1 2014 Update 6:45 a.m. April 24, 2014 - Seeking Alpha
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
European Stocks Rebound Amid M&A, Earnings Headlines 5:56 a.m. April 24, 2014 - TheStreet.com
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Pfizer Hosts Annual Meeting of ShareholdersDeclares 26-Cent Second-Quarter 2014 Dividend 10:50 a.m. April 24, 2014 - BusinessWire - BZX
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on JPMorgan Chase, Pfizer, General Motors, and Nokia 1:13 p.m. April 22, 2014 - PR Newswire - PRF
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis 8:01 a.m. April 22, 2014 - BusinessWire - BZX
Promotional Campaigns, Equity Awards, Stock Price Movements, New Launches, and Company Events - Analyst Notes on Pfizer, Intuitive Surgical, HCA Holdings, General Electric and John Deere 8:00 a.m. April 21, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders 1:20 p.m. April 18, 2014 - BusinessWire - BZX
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Premier Biomedical (BIEI) and the Wild West of Modern Medicine 10:25 a.m. April 14, 2014 - ACCESSWIRE
GlycoMimetics Announces Presentation of Data on Rivipansel (GMI-1070) in Combination with Current FDA-Approved Treatment for Sickle Cell Disease 9:02 a.m. April 14, 2014 - BusinessWire - BZX
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Acura Pharmaceuticals Announces Return of Product Rights 6:15 a.m. April 10, 2014 - Marketwire
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer 10:30 a.m. April 6, 2014 - BusinessWire - BZX
AMCP Foundation Launches Initiative to Identify Emerging Medication Management Practices that Can Advance Patient Care and Outcomes; Project Supported by Pfizer 12:38 p.m. April 3, 2014 - PR Newswire - PRF
Exosomes Shine a Light on Alzheimer's Disease and CTE 10:16 a.m. April 3, 2014 - ACCESSWIRE
AstraZeneca, Smith & Nephew push FTSE to 7-week high 12:31 p.m. April 24, 2014 - Sara Sjolin
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
Glaxo, AstraZeneca lead U.K. stocks to two-week high 12:50 p.m. April 22, 2014 - Carla Mozee
Drug stocks drive European markets higher 12:22 p.m. April 22, 2014 - Carla Mozee
Pfizer Psoriasis treatment shows positive results 9:35 a.m. April 22, 2014 - MarketWatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
European stocks rise as AstraZeneca, Glaxo climb 3:40 a.m. April 22, 2014 - Carla Mozee
Investors drive up AstraZeneca despite questions over potential Pfizer deal 12:00 p.m. April 21, 2014 - blogs.marketwatch.com
Pfizer held now-discontinued talks with AstraZeneca: report 2:18 a.m. April 21, 2014 - Barbara Kollmeyer
Acura Pharmaceuticals ends Pfizer licensing pact 7:10 a.m. April 10, 2014 - MarketWatch.com
U.S. stocks fall; Nasdaq 3-day loss worst since 2011 4:48 p.m. April 7, 2014 - Victor Reklaitis
Newscast: Wall Street extends recent selloff 4:28 p.m. April 7, 2014 - MarketWatch
Tesla, Facebook seesaw; Questcor surges on deal 3:54 p.m. April 7, 2014 - Ben Eisen
Pfizer shares drop despite positive test for breast-cancer drug 1:03 p.m. April 7, 2014 - blogs.marketwatch.com
Pfizer drops 2.5% to lead Dow decliners 9:35 a.m. April 7, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Pfizer anti-cholesterol drug meets main study goal 9:28 a.m. March 27, 2014 - MarketWatch.com
Apple looks ready to head higher 3:48 p.m. March 17, 2014 - blogs.marketwatch.com
Apple as the Comeback Kid 1:13 p.m. March 13, 2014 - Mark Hulbert
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. April 26, 2014 - 247WallSt.com
Assessing Pfizer's Future 3:43 a.m. April 26, 2014 - Barrons.com
Stocks Fall Slightly After a Jittery Friday 1:44 a.m. April 26, 2014 - Barrons.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Tracking Ken Fisher's Fisher Asset Management Portfolio - Q1 2014 Update 1:31 p.m. April 25, 2014 - Seeking Alpha
FDA Reviewing Psychiatric Side Effects of Pfizer's Chantix 11:50 a.m. April 25, 2014 - The Wall Street Journal Interactive Edition
Huge Opportunities Are Now Possible Due To Market Inefficiencies In Valuing Antibiotic Companies Such As Cubist, Durata, And Cellceutix 10:34 a.m. April 25, 2014 - Seeking Alpha
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. April 25, 2014 - Zacks.com
Cramer's Mad Money - Revenge Of The Nerds (4/24/14) 6:45 a.m. April 25, 2014 - Seeking Alpha
2 Clear Signs That Biotechs and Pharmaceuticals Have Peaked 5:55 a.m. April 25, 2014 - InvestorPlace.com
Generics Dent AstraZeneca Profit 3:12 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
AstraZeneca (AZN) Stock Higher Over Pfizer (PFE) Takeover Talk As Earnings Drop 12:31 p.m. April 24, 2014 - TheStreet.com
AstraZeneca Suffering from Split Personality 11:27 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Actavis Settles Celebrex Case With Pfizer 11:03 a.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Dow Today: Pfizer (PFE) Lower 11:00 a.m. April 24, 2014 - TheStreet.com
Trade-Ideas: Pfizer (PFE) Is Today's "Roof Leaker" Stock 10:12 a.m. April 24, 2014 - TheStreet.com
AstraZeneca could sell, spin off $15B worth of assets 7:59 a.m. April 24, 2014 - Seeking Alpha
30 And Under Portfolio: Q1 2014 Update 6:45 a.m. April 24, 2014 - Seeking Alpha
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
European Stocks Rebound Amid M&A, Earnings Headlines 5:56 a.m. April 24, 2014 - TheStreet.com
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Pfizer Hosts Annual Meeting of ShareholdersDeclares 26-Cent Second-Quarter 2014 Dividend 10:50 a.m. April 24, 2014 - BusinessWire - BZX
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on JPMorgan Chase, Pfizer, General Motors, and Nokia 1:13 p.m. April 22, 2014 - PR Newswire - PRF
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis 8:01 a.m. April 22, 2014 - BusinessWire - BZX
Promotional Campaigns, Equity Awards, Stock Price Movements, New Launches, and Company Events - Analyst Notes on Pfizer, Intuitive Surgical, HCA Holdings, General Electric and John Deere 8:00 a.m. April 21, 2014 - PR Newswire - PRF
Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders 1:20 p.m. April 18, 2014 - BusinessWire - BZX
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Premier Biomedical (BIEI) and the Wild West of Modern Medicine 10:25 a.m. April 14, 2014 - ACCESSWIRE
GlycoMimetics Announces Presentation of Data on Rivipansel (GMI-1070) in Combination with Current FDA-Approved Treatment for Sickle Cell Disease 9:02 a.m. April 14, 2014 - BusinessWire - BZX
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts 9:00 a.m. April 11, 2014 - BusinessWire - BZX
Acura Pharmaceuticals Announces Return of Product Rights 6:15 a.m. April 10, 2014 - Marketwire
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
Enrollment in Expansion Phase of Trials, Results and Initiation of Phase 2 Studies and Stock Movements - Analyst Notes on Pfizer, Cytokinetics, Portola Pharmaceuticals, Volcano, and Array BioPharma 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept 8:00 a.m. April 7, 2014 - PR Newswire - PRF
Pfizer’s Novel CDK 4/6 Inhibitor Palbociclib plus Letrozole Significantly Prolonged Progression-Free Survival in Patients with Advanced Breast Cancer 10:30 a.m. April 6, 2014 - BusinessWire - BZX
AMCP Foundation Launches Initiative to Identify Emerging Medication Management Practices that Can Advance Patient Care and Outcomes; Project Supported by Pfizer 12:38 p.m. April 3, 2014 - PR Newswire - PRF
Exosomes Shine a Light on Alzheimer's Disease and CTE 10:16 a.m. April 3, 2014 - ACCESSWIRE
(0)
(0)
